Thomas Jefferson University, Philadelphia
Cardiac resynchronization therapy not recommended for right bundle branch block
Published in Law and Health Weekly, July 30th, 2005
"Clinical trials of cardiac resynchronization therapy (CRT) have not included many patients with right bundle branch block (RBBB). We pooled data from two randomized controlled trials of CRT (Multicenter InSyne Randomized Clinical Evaluation [MIRACLE] and Contak CD) in order to assess outcomes of patients with RBBB," said C.A. Egoavil and colleagues, Thomas Jefferson University.
"A total of 61 patients with RBBB were identified, 34 of whom were randomized to the CRT group and 27 to the control group. The data from these patients were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Ciphergen Biosystems, Inc.
Novel approach to detect cancer measures fragments of host response proteins - Hacettepe University, Ankara
N-acetylcysteine treatment has no prophylactic use - Istituto Nazionale Tumori Fond. G. Pascale
HIV-1 clade A virus-like particles elicit neutralizing antibodies - Medtronic, Inc.
Technology company purchases land for new headquarters, launches online resource - Myriad Genetics, Inc.
Biopharmaceutical company announces patent on amyloid lowering drugs - NMT Medical, Inc.
Medical technology company initiates patent foramen ovale closure study - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
